Immunohistochemical evaluation of p53 and Retinoblastoma proteins in relation to hyperthermia treatment: Results in human urothelial carcinomas

International Journal of Hyperthermia

Volumn 12, Issue 6, 1996, Pages 813-824

  Okamura, T ^a   Ueda, K ^a   Hashimoto, Y ^a   Tozawa, K ^a   Kohri, K ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Hyperthermia; Immunohistochemistry; p53; RB; Urothelial carcinoma

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CLINICAL ARTICLE; CYSTECTOMY; FEMALE; HEAT SENSITIVITY; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UNDIFFERENTIATED CARCINOMA; URETER CARCINOMA; UROGENITAL TRACT CANCER;

EID: 0029801168     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609027687     Document Type: Article

References (35)

1. ANDREWS, G. K., HARDING, M. A., CALVET, J. P. and ADAMSON, E. D., 1987, The heat shock response in HeLa cells is accompanied by elevate expression of the c-fos proto-oncogene. Molecular and Cellular Biology, 7, 3452-3458.
2. ARMITAGE, P., 1973, Statistical methods in medical research (Oxford, England: Blackwell Scientific), pp. 135.
3. CAIRNS, P., PROCTOR, A. J., and KNOWLES, M. A., 1991, Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene, 6, 2305-2309.
4. CORDON-CARDO, C., FINSTAD, C. L., BANDER, N. H., and MELAMED, M. R., 1987, Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. American Journal of Pathology, 126, 269-284.
5. CORDON-CARDO, C., WARTINGER, D., PETRYLAK, D., DALBAGNI, G., FAIR, W. R., FUKS, Z., and REUTER, V. E., 1992, Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. Journal of the National Cancer Institute, 84, 1251-1256.
6. DALBAGNI, G., PRESTI, J., REUTER, V., FAIR, W. R., and CORDON-CARDO, C., 1993, Genetic alterations in bladder cancer. Lancet, 342, 469-471.
7. ENGELHARDT, R., MÜLLER, V., and WETH-SIMON, R., 1990, Treatment of disseminated malignant melanoma with cisplatin in combination with whole body hyperthermia and doxorubicin. International Journal of Hyperthermia, 6, 511-515.
8. FAN, S., EL-DEIRY, W. S., BAE, I., FREEMAN, J., JONDLE, D., BHATIA, K., FORNACE, JR., A. J., MAGRATH, I., KOHN, K. W. and O'CONNOR, P. M., 1994, p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Research, 54, 5824-5830.
9. FUJIMOTO, K., YAMADA, Y., OKAJIMA, E., KAKIZOE, T., SASAKI, H., SUGIMURA, T., and TERADA, M., 1992. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Research, 52, 1393-1398.
10. HABUCHI, T., TAKAHASHI, R., YAMADA, H., OGAWA, O., KAKEHI, Y., OGURA, K., HAMAZAKI, S., TOGUCHIDA, J., ISHIZAKI, K., FUJITA, J., SUGIYAMA, T. and YOSHIDA, O., 1993, Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Research, 53, 3795-3799.
11. HAINAUT, P., and MILNER, J., 1992, Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. The EMBO Journal, 11, 3513-3520.
12. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTAIN, B., and HARRIS, C. C., 1991, p53 mutations in human cancers. Science, 253, 49-53.
13. ISHIKAWA, J., XU, H. J., HU, S. X., YANDELL, D. W., MAEDA, S., KAMIDONO, S., BENEDICT, W. F., and TAKAHASHI, R., 1991, Inactivation of retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Research, 51, 5736-5743.
14. KASID, U., PFEIFER, A., WEICHSELBAUM, R. R., DRITSCHILO, A. and MARK, G. E., 1987, The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science, 237, 1039-1041.
15. KUBOTA, Y., YAO, M., ISHIBASHI, Y., MIURA, T., SHUIN, T., HOSADA, M., TAKEBAYASHI, S., WATAI, K., and MATSUI, K., 1988, The use of capacitive type shortwave radio-frequency hyperthermia in the treatment of urological cancers. Regional Cancer Treatment, 1, 117-122.
16. LEVINE, A. J., MOMAND, J., and FINLAY, C. A., 1991, The p53 tumor suppressor gene. Nature, 351, 453-456.
17. LOWE, S. W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H. E., FISHER, D. E., HOUSMAN, D. E., and JACKS, T., 1994, p53 status and the efficacy of cancer therapy in vivo Science, 266, 807-810.
18. MASUNAGA, S., HIRAOKA, M., TAKAHASHI, M., JO, S., AKUTA, K., NISHIMURA, Y., NAGATA, Y., and ABE, M., 1990a, Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer-comparison of results with radiotherapy alone. International Journal of Hyperthermia, 6, 489-497.
19. MASUNAGA, S., HIRAOKA, M., AKUTA, K., NISHIMURA, Y., NAGATA, Y., JO, S., TAKAHASHI, M., and ABE, M, 1990b, Non-randomized trials of thermoradiotherapy versus radiotherapy for preoperative treatment of invasive urinary bladder cancer. The Journal of The Japanese Society for Therapeutic Radiology and Oncology, 2, 313-320.
20. MØRKVE, O., and HØSTMARK, J., 1991, Influence of tissue preparation techniques on p53 expression in bronchial and bladder carcinomas, assessed by immunofluorescence staining and flow cytometry, Cytometry, 12, 622-627.
21. NAGATA, Y., HIRAOKA, M., AKUTA, K, ABE, M., TAKAHASHI, M., JO, S., NISHIMURA, Y., MASUNAGA, S., FUKUDA, M., and IMURA, H., 1987, Radiofrequency thermotherapy for malignant liver tumors. Cancer, 65, 1730-1736.
22. r 73,000 heat shock cognate protein. Cancer Research, 53, 1702-1705.
23. OVERGAARD, J., 1989, The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology and Physics, 16, 535-549.
24. PEREZ, C. A., PAJAK, T., EMAMI, B., HORNBACK, N. B., TUPCHONG, L., and RUBIN, P., 1991, Randomized phase 3 study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors: final report by the Radiation Therapy Oncology Group. American Journal of Clinical Oncology, 14, 133-141.
25. PRESTI, JR J. C., REUTER, V. E., GALAN, T., FAIR, W. R., and CORDON-CARDO, C., 1991, Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Research, 51, 5405-5409.
26. SIDRANSKY, D., VON ESCHENBACH, A., TSAI, Y. C., JONES, P., SUMMERHAYES, I., MARSHALL, F., PAUL, M., GREEN, P., HAMILTON, S. R., FROST, P., and VOGELSTEIN, B., 1991, Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706-709.
27. SNEED, P. K., GUTIN, P. R., STAUFFER, P. R., PHILLIPS, T. L., PRADOS, M. D., WEAVER, K. A., SUEN, S., LAMB, S. A., HAM, B., AHN, D. K., LAMBORN, K., LARSON, D. A., and WARA, W. M., 1992, Thermoradiotherapy of recurrent malignant brain tumors. International Journal of Radiation Oncology, Biology and Physics, 23, 853-863.
28. SPRUCK III, C. H., RIDEOUT III, W. M., OLUMI, A. F., OHNESEIT, P. F., YANG, A. S., TSAI, Y. C., NICHOLS, P. W., HORN, T., HARMANN, G. G., STEVEN, K., ROSS, R. K., YU, M. C., and JONES, P. A., 1993, Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Research, 53, 1162-1166.
29. SPRUCK III, C. H., OHNESEIT, P. F., GONZALEZ-ZULUETA, M., ESRIG, D., MIYAO, N., TSAI, Y. C., LERNER, S. P., SCHMÜTTE, C., YANG, A. S., COTE, R., DUBEAU, L., NICHOLS, P. W., HARMANN, G. G., STEVEN, K., HORN, T., SKINNER, D. G., and JONES, P. A., 1994, Two molecular pathways to transitional cell carinoma of the bladder. Cancer Research, 54, 784-788.
30. STORM, F. K., 1989, Clinical hyperthermia and chemotherapy. Radiologic Clinics of North America, 27, 621-627.
31. SUZUKI, K., WATANABE, M. and MIYOSHI, J., 1992, Differences in effects of oncogenes on resistance to γ rays, ultraviolet light, and heat shock. Radiation Research, 129, 157-162.
32. TAIRA, T., NEGISHI, Y., KIHARA, F., IGUCHI-ARIGA, S. M. M., and ARIGA, H., 1992, c-myc protein complex binds to two sites in humkan hsp70 promoter region. Biochemica et Biophysica Acta, 1130, 166-174.
33. UICC, 1978, TNM classification of malignant tumors. Third Edition, Geneva.
34. VALDAGNI, R., AMICHETTI, M., and PANI, G., 1988, Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized trial. International Journal of Radiation Oncology, Biology and Physics, 15, 13-24.
35. XU, H. J., CAIRNS, P., HU, S. X., KNOWLES, M. A. and BENEDICT, W. F., 1993, Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. International Journal of Cancer, 53, 781-784.